Philip Gerretsen, MD, PhD, FRCPC
- 5Articles
- 19.6KReads
- 2011–2017Active
- 20Collaborators
- 189Citations
About
Philip Gerretsen, MD, PhD, FRCPC, has published extensively on cognition and neuropsychiatric conditions including schizophrenia, schizoaffective disorders, Alzheimer disease, and major depressive disorder. His research topics cover anosognosia and brain metabolism in mild cognitive impairment, insight and cognition in schizophrenia, dopamine receptor occupancy related to hyperprolactinemia in older patients with schizophrenia, and the impact of impaired insight on treatment outcomes in psychotic depression. He has also examined adverse anticholinergic effects. His work appeared in Psychiatrist.com from 2011 to 2017.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
